scispace - formally typeset
P

Paul Ernsberger

Researcher at Case Western Reserve University

Publications -  168
Citations -  11411

Paul Ernsberger is an academic researcher from Case Western Reserve University. The author has contributed to research in topics: Receptor & Imidazoline receptor. The author has an hindex of 50, co-authored 168 publications receiving 10878 citations. Previous affiliations of Paul Ernsberger include University of Mississippi & University of Minnesota.

Papers
More filters
Journal ArticleDOI

Relating protein pharmacology by ligand chemistry

TL;DR: This work began with 65,000 ligands annotated into sets for hundreds of drug targets, and found that methadone, emetine and loperamide (Imodium) may antagonize muscarinic M3, α2 adrenergic and neurokinin NK2 receptors, respectively.
Journal ArticleDOI

H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs

TL;DR: It is recommended that the next generation of atypical antipsychotic drugs be screened to avoid H1-histamine receptors, which are known to induce weight gain with chronic use.
Journal ArticleDOI

Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist

TL;DR: Salvinorin A is the first naturally occurring nonnitrogenous opioid-receptor subtype-selective agonist for κ opioid receptors and may represent novel psychotherapeutic compounds for diseases manifested by perceptual distortions (e.g., schizophrenia, dementia, and bipolar disorders).
Journal ArticleDOI

The epidemiology of overweight and obesity: public health crisis or moral panic?

TL;DR: This article evaluates four central claims made by those calling for intensifying the war on fat: that obesity is an epidemic; that overweight and obesity are major contributors to mortality; that higher than average adiposity is pathological and a primary direct cause of disease; and that significant long-term weight loss is both medically beneficial and a practical goal.
Journal ArticleDOI

Clonidine binds to imidazole binding sites as well as α2-adrenoceptors in the ventrolateral medulla

TL;DR: Describing binding sites labeled by [3H]p-aminoclonidine in bovine brain membranes prepared from the ventrolateral medulla found that these sites may mediate, in part, the hypotensive action of clonidine and other imidazole compounds in the ventral medulla.